TestingLandmark

2019 ESC/EAS guidelines for the management of dyslipidaemias (Mach et al., EHJ 2020)

Original title: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Eur Heart J · 1 January 2020 · 8

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A et al.

The European guideline that first recommended Lp(a) measurement at least once in every adult's lifetime, to identify people with very high inherited levels (above 180 mg/dL, about 430 nmol/L) whose lifetime ASCVD risk equals heterozygous FH, and to use Lp(a) as a risk modifier in people at borderline risk. The 2025 focused update builds on it.

Read the paper (DOI)PubMed

guidelines testing

Summary written by lp-a.org from the published abstract; figures as published. Page updated 17 August 2026. Methods.